Year-end Sale % OFF 
Abstract
BackgroundTo identify indicators of guideline-concordant care in lung cancer, to implement such indicators with cancer registry data linked to health databases, and to pilot them in a cohort of patients from the cancer registry of the Milan Province.MethodsThirty-four indicators were selected by revision of main guidelines by cancer epidemiologists, and then evaluated by a multidisciplinary panel of clinicians involved in lung cancer care and working on the pathway of lung cancer diagnosis and treatment in the Lombardy region, Italy. With a modified Delphi method, they assessed for each indicator the content validity as a quality measure of the care pathway, the degree of modifiability from the health professional, and the relevance to the health professional. Feasibility was assessed using the cancer registry and the routine health records of the Lombardy region. Feasible indicators were then calculated in the cohort of lung cancer patients diagnosed in 2007–2012 derived from the cancer registry of the Milan Province. Criterion validity was assessed reviewing clinical records of a random sample of 114 patients (threshold for acceptable discordance ≤20%). Finally, reliability was evaluated at the provider level.ResultsInitially, 34 indicators were proposed for evaluation in the first Delphi round. Of the finally 22 selected indicators, 3 were not feasible because the required information was actually not available. The remaining 19 were calculated on the pilot cohort. After assessment of criterion validity (3 eliminated), 16 indicators were retained in the final set and evaluated for reliability.ConclusionThe developed and piloted set of indicators is now available to implement and monitor, over time, quality initiatives for lung cancer care in the studied health system.
Highlights
To identify indicators of guideline-concordant care in lung cancer, to implement such indicators with cancer registry data linked to health databases, and to pilot them in a cohort of patients from the cancer registry of the Milan Province
Lung cancer remains a killer disease being the leading cause of cancer death for both genders in countries with a high Human Development Index (HDI), with world age-standardized mortality rates of 36.4 per 100,000 for males and 14.6 per 100,000 for females, accounting for approximately 22% of all cancer deaths in 2018 [1]. This despite the discontinuation in smoking habit occurred in high HDI countries that led to a reduction of incidence rates [2]
Indicators have to be timely, reliable and economically computable on a large scale to inform quality improvement activities [10, 11]. This is impractical if indicators are retrospectively computed using data abstracted ad hoc from clinical records, while it is expected to be feasible using current health database linked to modern population cancer registers [12,13,14]
Summary
To identify indicators of guideline-concordant care in lung cancer, to implement such indicators with cancer registry data linked to health databases, and to pilot them in a cohort of patients from the cancer registry of the Milan Province. Lung cancer remains a killer disease being the leading cause of cancer death for both genders in countries with a high Human Development Index (HDI), with world age-standardized mortality rates of 36.4 per 100,000 for males and 14.6 per 100,000 for females, accounting for approximately 22% of all cancer deaths in 2018 [1]. This is impractical if indicators are retrospectively computed using data abstracted ad hoc from clinical records, while it is expected to be feasible using current health database linked to modern population cancer registers [12,13,14]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
